These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1435 related items for PubMed ID: 33246024

  • 1. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 2. A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.
    Faucon AL, Fu EL, Stengel B, Mazhar F, Evans M, Carrero JJ.
    Kidney Int; 2023 Sep; 104(3):542-551. PubMed ID: 37330214
    [Abstract] [Full Text] [Related]

  • 3. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM.
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [Abstract] [Full Text] [Related]

  • 4. Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.
    Fu EL, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW, Carrero JJ.
    J Am Soc Nephrol; 2021 Feb; 32(2):424-435. PubMed ID: 33372009
    [Abstract] [Full Text] [Related]

  • 5. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ, Li Y, Liu SM, Sun XG, Li M, Hao Y, Cui LQ, Wang AH.
    Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
    [Abstract] [Full Text] [Related]

  • 6. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

  • 7. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS, Cheng YM, Zeng XX, Kim S, Fu P.
    Chin Med J (Engl); 2016 Mar 05; 129(5):562-9. PubMed ID: 26904991
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.
    JAMA Intern Med; 2014 Mar 05; 174(3):347-54. PubMed ID: 24343093
    [Abstract] [Full Text] [Related]

  • 9. Comparative effectiveness of first-line antihypertensive drug classes on the maintenance of estimated glomerular filtration rate (eGFR) in real world primary care.
    Gao Q, Tan NC, Lee ML, Hsu W, Choo J.
    Sci Rep; 2023 Dec 01; 13(1):21225. PubMed ID: 38040765
    [Abstract] [Full Text] [Related]

  • 10. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M.
    Am J Kidney Dis; 2021 Aug 01; 78(2):190-199.e1. PubMed ID: 33434591
    [Abstract] [Full Text] [Related]

  • 11. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y, He D, Zhang W, Xing Y, Guo Y, Wang F, Jia J, Yan T, Liu Y, Lin S.
    Drugs; 2020 Jun 01; 80(8):797-811. PubMed ID: 32333236
    [Abstract] [Full Text] [Related]

  • 12. Association of ACEI/ARB therapy with total and cardiovascular death in coronary artery disease patients with advanced chronic kidney disease: a large multi-center longitudinal study.
    Lai W, Zhao X, Zhang T, Huang D, Liang G, Zhou Y, Liu J, Chen S, Liu Y.
    Ren Fail; 2024 Dec 01; 46(2):2398189. PubMed ID: 39229915
    [Abstract] [Full Text] [Related]

  • 13. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L.
    Nephron; 2019 Dec 01; 143(2):100-107. PubMed ID: 31203280
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T.
    J Am Coll Cardiol; 2016 Apr 12; 67(14):1687-97. PubMed ID: 27056774
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 16. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
    Schroeder EB, Chonchol M, Shetterly SM, Powers JD, Adams JL, Schmittdiel JA, Nichols GA, O'Connor PJ, Steiner JF.
    Clin J Am Soc Nephrol; 2018 May 07; 13(5):727-734. PubMed ID: 29572286
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC, Wu YT, Yang WC, Tsai MJ, Liu JS, Yang CY, Li SY, Ou SM, Tarng DC, Hsu CC.
    PLoS One; 2017 May 07; 12(12):e0189126. PubMed ID: 29216260
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
    Jeong HS, Lim HS, Park HJ, Lee WS, Choi JO, Lee HS, Jo SH, Hong SJ.
    Sci Rep; 2021 Jan 19; 11(1):1783. PubMed ID: 33469103
    [Abstract] [Full Text] [Related]

  • 19. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S, ITA-COVID-19: RAAS inhibitor group.
    Drug Saf; 2020 Dec 19; 43(12):1297-1308. PubMed ID: 32852721
    [Abstract] [Full Text] [Related]

  • 20. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC.
    J Nephrol; 2017 Apr 19; 30(2):281-288. PubMed ID: 27485007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.